Joseph M. Lipner

David I. Gindler

Kevin S. Prussia

Sonal N. Mehta

Daralyn J. Durie

Richard W. O'Neill

Robert J. Gunther, Jr.

Adam R. Brausa

Leeron Morad

Nora Q. E. Passamaneck

Matthew A. Traupman

Jeffrey E. Ostrow

Amanda K. Antons

Laura L. Fairneny

Raymond N. Nimrod

Adam Wolfson

Katherine A. Helm

Michael B. Bruns

Paul J. Slattery

Merck challenges Genentech patent covering KEYTRUDA®, alleging a 28-year prosecution delay created an invalid monopoly on `recombinant antibody` production.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Merck Sharp & Dohme Corp	L5 A
Merck Sharp & Dohme LLC	L5 A

Name	Ratings
Quinn Emanuel Urquhart & Sullivan LLP	L5 A
Matthew A. Traupman	L5 C
Raymond N. Nimrod	L4 B
Laura L. Fairneny	L2 A
Amanda K. Antons	L2 B
Adam Wolfson	-- -- --
Michael B. Bruns	-- -- --
Paul J. Slattery	-- -- --
Simpson Thacher & Bartlett LLP	L2 C
Jeffrey E. Ostrow	L5 A
Katherine A. Helm	-- -- --

Name	Ratings
Genentech Inc	L4 A
City of Hope	L2 C

Name	Ratings
Wilmer Cutler Pickering Hale Dorr LLP	L5 A
Robert J. Gunther, Jr.	L4 E
Richard W. O'Neill	L3 D
Kevin S. Prussia	L2 D
Nora Q. E. Passamaneck	-- -- --
Durie Tangri LLP	L5 A
Daralyn J. Durie	L5 A
Sonal N. Mehta	L4 C
Leeron Morad	L2 B
Adam R. Brausa	L1 B
Irell & Manella LLP	L4 C
David I. Gindler	L5 A
Joseph M. Lipner	L4 B

2:16-cv-04992

Merck Sharp & Dohme Corp v. Genentech Inc